A critical advance in cancer research is arising with the use of nanobodies to re-engage mutated p53. This essential tumor protector protein is frequently disabled in several types of cancer, leading uncontrolled https://webookmarks.com/story7622103/mini-antibodies-revive-the-p53-protein-the-promising-approach-for-cancer-therapy